相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A)
Evan D. Kharasch et al.
ANESTHESIOLOGY (2012)
Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics
E. D. Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Intraoperative Methadone: Rediscovery, Reappraisal, and Reinvigoration?
Evan D. Kharasch
ANESTHESIA AND ANALGESIA (2011)
Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation
Yan Chang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Exposure to Oral S-ketamine Is Unaffected by Itraconazole but Greatly Increased by Ticlopidine
M. A. Peltoniemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effects of Clopidogrel on the Pharmacokinetics of Sibutramine and Its Active Metabolites
Jung-Woo Bae et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer
Sheng-Chang Wang et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response
Francina Fonseca et al.
PLOS ONE (2011)
Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence
Ali S. Saber-Tehrani et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2011)
The pharmacological treatment of opioid addiction-a clinical perspective
Philipp Lobmaier et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Methadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)
Wenjie Jessie Lu et al.
DRUG METABOLISM AND DISPOSITION (2010)
Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review
Elinore F. McCance-Katz et al.
AMERICAN JOURNAL ON ADDICTIONS (2010)
Methadone Pharmacokinetics Are Independent of Cytochrome P4503A (CYP3A) Activity and Gastrointestinal Drug Transport Insights from Methadone Interactions with Ritonavir/Indinavir
Evan D. Kharasch et al.
ANESTHESIOLOGY (2009)
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment
Mohammad-Reza Shiran et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity
Evan D. Kharasch et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Roger Chou et al.
JOURNAL OF PAIN (2009)
Role of CYP2B6 in stereoselective human methadone metabolism
Rheem A. Totah et al.
ANESTHESIOLOGY (2008)
Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir
Evan D. Kharasch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance
E. D. Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam
E. D. Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Surveillance of methadone-related adverse drug events using multiple public health data sources
Shannon A. Sims et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2007)
Enantiomeric metabolic interactions and stereoselective human methadone metabolism
Rheem A. Totah et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
ABCB1 and cytochrome P450 genotypes and phenotypes:: Influence on methadone plasma levels and response to treatment
Severine Crettol et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Lack of an effect of atazanavir on steady-state pharmacokineties of methadone in patients chronically treated for opiate addiction
G Friedland et al.
AIDS (2005)
Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity
ED Kharasch et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Effect of clopidogrel and ticlopidine on cytochrome P4502B6 activity as measured by bupropion hydroxylation
M Turpeinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
ED Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine
T Richter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
JG Gerber et al.
CHIRALITY (2004)
Interindividual variability of the clinical pharmacokinetics of methadone - Implications for the treatment of opioid dependence
CB Eap et al.
CLINICAL PHARMACOKINETICS (2002)
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P4502C19
NT Ha-Duong et al.
BIOCHEMISTRY (2001)
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients
DJR Foster et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
